| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.006 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |